Full Judgment Text
Text read from the judgment PDF published on the High Court's eCourts portal, through the
Indian High Court Judgments open data set (Dattam Labs,
CC BY 4.0).
The court's own copy is the authoritative text.
THE HIGH COURT OF SIKKIM : GANGTOK
(Civil Extraordinary Jurisdiction)
DATED : 5th February, 2021
----------------------------------------------------------------------------------THE HON’BLE MRS. JUSTICE MEENAKSHI MADAN RAI, JUDGE
THE HON’BLE MR. JUSTICE BHASKAR RAJ PRADHAN, JUDGE
DIVISION BENCH :
-----------------------------------------------------------------------------------
WP(C) No.47 of 2018
Petitioner
:
Sun Pharma Laboratories Limited
versus
Respondents :
Union of India and Others
Petition under Article 226 of the
Constitution of India
------------------------------------------------------------------Appearance
Mr. V. Lakshmi Kumaran, Mr. Karan Sachdev and Ms. Gita Bista,
Advocates for the Petitioner.
Mr. B.K. Gupta, Advocate for Respondents No.1 and 2.
Mr. S.K. Chettri, Government Advocate for Respondent No.3.
-------------------------------------------------------------------
JUDGMENT
Meenakshi Madan Rai, J.
1.
The Petitioner herein assails the restrictions imposed
by the Scheme of Budgetary Support, issued under the Goods and
Services
Tax
regime
vide
Notification
F.No.10(1)/2017-DBA-
II/NER, dated 05.10.2017, by the Respondent No.1, reducing the
quantum of benefits earlier availed by the Petitioner, thereby
reneging on the promises made under the erstwhile Tax regime
and adversely affecting the Petitioner.
1.(a)
The Petitioner is a Private Limited Company engaged
inter alia in the manufacture of P&P Medicaments and Consumer
Health Products for which purpose Unit I was set up on 2005 and
Unit II later in time, both situated at Ranipool, East Sikkim.
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
1.(b)
vs.
Union of India and Others
The Petitioner’s case is that vide a Memorandum, dated
17.02.2003, the Respondent No.1 notified the “New Industrial
Policy and other concessions for the State of Sikkim” (“Industrial
Policy, 2003”) which inter alia granted 100 per cent exemption
from Excise duty for a period of ten years from the date of
commencement
of
commercial
production.
Pursuant
thereto,
various exemption Notifications were issued under the respective
Fiscal
Statutes,
including
Central
Excise
original
Notification
No.56/2003-C.E., dated 25.06.2003. By this Notification, 100 per
cent duty exemption was granted to the goods specified in the
Schedule thereto, manufactured and cleared from a Unit located in
Sikkim from so much of the duty of Excise leviable under the
Central Excise Act, 1944 and other allied Acts as is equivalent to
the amount of duty paid by the manufacturer of the goods other
than the amount of duty paid by utilization of CENVAT Credit under
the CENVAT Credit Rules, 2002 for a period of ten years from the
date of commencement of commercial production.
1.(c)
On 01.04.2007, the Respondent No.1 notified the North
East Industrial and Investment Promotion Policy, 2007 (“Industrial
Policy, 2007”) thereby discontinuing the Industrial Policy of 2003.
The Industrial Policy of 2007 also covered the State of Sikkim and
inter alia provided that the new Units and existing Units which go
in for substantial expansion and commence commercial production
within ten years of the date of Notification of the said Policy, would
be eligible for incentives for a period of ten years from the date of
commencement of commercial production. It further provided that
100 per cent Excise duty exemption would be continued on finished
products made in the North Eastern Region as available under
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
NEIP, 1997. However, in cases where the CENVAT paid on the raw
materials and intermediate products going into the production of
finished products (other than the products which are otherwise
exempt or subject to nil rate of duty) is higher than the Excise
Duties payable on the finished products, ways and means to refund
such overflow of CENVAT Credit will be separately notified by the
Ministry of Finance.
1.(d)
Based on the representations of the Respondent No.1,
the Petitioner, by making substantial investments, set up the first
Unit
in
and
commenced
commercial
production
on
20.04.2009. The second Unit set up later, commenced commercial
production on 14.04.2014. Thus both Units started its commercial
production within ten years from the date of issuance of Industrial
Policy, 2007 and were enjoying the full refund of the Central Excise
Duties paid by them by way of the mechanism provided in the
exemption Notification.
1.(e)
It
is
alleged
that
Notifications
No.21/2008-C.E.
27.03.2008,
amending
the
Respondent
No.1
issued
and
20/2008-C.E.,
both
dated
No.56/2003-C.E.,
dated
Notifications
25.06.2003 and 20/2007-C.E., dated 25.04.2007, to curtail 100
per cent Excise duty exemption provided thereof. The benefit of
exemption was sought to be reduced to the prescribed percentage
of
value
addition
amount
i.e.
per
cent
applicable
to
pharmaceutical products mentioned in the respective Notifications
and applicable Chapter. These amendments were challenged before
this Court by the Petitioner in W.P.(C) No.41/2015, W.P.(C)
No.08/2017, W.P.(C) No.27/2017 and W.P.(C) No.40/2017 and this
Court quashed the impugned Notifications No.20/2008-C.E., dated
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
27.03.2008 and 38/2008-C.E., dated 10.06.2008, vide Judgment
dated 21.11.2017.
1.(f)
From 01.07.2017, the entire indirect Tax regime in the
country underwent a major reform with the introduction of the
Goods and Services Tax (“GST”) which thereby introduced the
Central Goods and Services Tax Act, 2017 (for short “CGST Act”),
the Integrated Goods and Services Tax Act, 2017 (for short “IGST
Act”) and the Sikkim Goods and Service Tax Act, 2017. Section
174 of the CGST Act repealed the Central Excise Act, 1944 with
certain exceptions and vide Notification No.21/2017-C.E., dated
18.07.2017,
the
Respondent
No.1
rescinded
Notifications
No.20/2007-C.E., dated 25.04.2007 and 56/2003-C.E., dated
25.06.2003.
1.(g)
In continuation of the earlier Industrial Policies as well
as Excise Notifications to exempt the levy of Central Excise duty on
the Goods manufactured and sold from the Units in the State of
Sikkim, the Central Government provided for Budgetary Support
Schemes for such Units under the GST regime. The Budgetary
Support Scheme is applicable to the Units which were eligible for
drawing benefits under the earlier Excise Duty Exemption/Refund
Schemes and was applicable for the remaining period out of the
total
period
not
exceeding
ten
years,
from
the
date
of
commencement of commercial production as specified under the
erstwhile Notification. The amount of Budgetary Support under the
Scheme for specified goods manufactured by the eligible Unit is
specified as the sum total of 58 per cent of the Central Tax paid
through debit in cash ledger account maintained by the Unit after
full utilization of the input Tax Credit of the Central Tax and
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
Integrated Tax and 29 per cent of the Integrated Tax paid through
debit in cash ledger account maintained by the Unit after full
utilization of the input Tax Credit of the Central Tax and Integrated
Tax. The Excise Duty Exemptions availed by the Petitioner by way
of refund in the pre GST regime, for both the Units were curtailed
by the Respondent No.1 through the Budgetary Support Policy
thereby reducing the benefit granted to the Petitioner. Therefore,
the reduction in benefits on the supply of goods by the Petitioner is
contrary to Article 14 of the Constitution of India (for short
“Constitution”) and the Petitioner’s right to avail the benefit of
exemption cannot be taken away by the limited benefit provided
under the Budgetary Support Scheme. That, the Respondent No.1
is estopped from imposition of CGST which was represented by
them to be 100 per cent exempt for the specified period. Hence,
the prayers in the Writ Petition.
2.
Denying and disputing the allegations of the Petitioner,
the Respondents No.1 and 2 in their Counter-Affidavit, reagitated
that Notification No.20/2007-C.E., dated 25.04.2007, which was
subsequently amended by Notification No.20/2008-C.E., dated
27.03.2008, was issued well before the Petitioner started its
commercial production, which started after the amendment of
exemption
Notification
restricting
the
refund.
That,
the
confinement of 58 per cent of the Central Goods and Services Tax
(for short “CGST”) and 29 per cent of the Integrated Goods and
Services Tax (for short “IGST”), has been fixed taking into
consideration that at present the Central Government devolves 42
per cent of the Taxes on Goods and Services to the States, as per
the recommendation of the 14th Finance Commission. Moreover,
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
the power of exemption is variously described as conditional
legislation and also a piece of delegated legislation. This power of
the Central Government has to be exercised in public interest and
there is no warrant for reading any limitation into this power. That,
the new Budgetary Support Scheme is launched as a measure of
goodwill only to the Units which were eligible for drawing benefits
under the earlier Excise Duty Exemption/Refund Schemes but
otherwise has no relation to the erstwhile Schemes and it is
impossible to compare the benefits under the old Scheme and the
new Scheme, neither is it feasible or desirable. This has been
considered by the Central Government to be expedient in public
interest and for revenue. That, in fact, the Petitioner has availed
benefits extended by the Government under the Budgetary
Support Scheme for various periods from July, 2017 through
December, 2017 and after availing the benefits, they have filed the
instant Writ Petition which is arbitrary and bad in law, on which
ground alone the Petition deserves a dismissal. Moreover, the full
benefit in respect of the share of the Central Revenue is being
granted to the Petitioner and they have been availing of the said
benefit from the Department. Hence, for the aforestated reasons,
the Writ Petition is liable to be rejected.
3.
The Respondent No.3 chose not to file any Counter-
Affidavit.
4.
A Rejoinder was filed to the Counter-Affidavit of
Respondents No.1 and 2 which, while reiterating the facts stated in
the Petition, emphasized that the Respondents No.1 and 2 have
not cited the public interest which necessitated the curtailment of
benefits promised to the Petitioner under the erstwhile law.
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
5.(i)
vs.
Union of India and Others
Learned Counsel Mr. V. Lakshmi Kumaran for the
Petitioner, while relying and reiterating the averments made in the
Petition, contended that if the value addition norms were met, then
even under the said Scheme, the manufacturer could avail 100 per
cent exemption on the Excise duty paid through cash. That, in the
Appeals filed by the Department, the Hon’ble Supreme Court in
Union of India and Another vs. V.V.F. Limited and Another 1 set aside
the Judgments passed by the various High Courts including the
Judgment of this High Court passed on 21.11.2017 however, the
Judgment (V.V.F. Limited supra) does not conclusively decide the
issues raised in the instant Petition.
(ii)
It was next contended that the Respondents have
acted against their promises and reduced the benefits promised to
the Petitioner. That, the Budgetary Support Scheme makes a
departure from the erstwhile Scheme restricting the Budgetary
Support which is de hors the value addition norms and limits the
benefits available even if value addition norms are met. It was
submitted that the principle of Promissory Estoppel is applicable in
the instant case as the Respondents have failed to demonstrate
any supervening public interest. That, the Hon’ble Supreme Court
in V.V.F. Limited (supra) has not diluted the principle of Promissory
Estoppel which would continue to apply in the present case,
consequently this Court must independently examine whether the
present amendment violates the said principle. That, the Hon’ble
Supreme Court, in fact, noted that the principle is applicable in all
cases except in cases of supervening public interest which
necessitates withdrawal of benefits so promised. In light of this
(2020) SCC Online SC 378
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
settled principle,
the
Hon’ble
vs.
Union of India and Others
Supreme
Court examined the
reduction in Excise duty exemption benefits and held that the
subsequent Notifications were merely clarificatory in nature and did
not take away any vested right and were issued in the larger public
interest to prevent misuse and to achieve the original object and
purpose of the incentive/exemption. The attention of this Court
was invited to Paragraphs 14 and 15 of the said ratio. Support in
this context was garnered from the ratio of SL Srinavasa Jute Twine
Mills (P) Ltd.
Vs.
Union of India2
and Southern Petrochemicals
Industries Co. Ltd. vs. Electricity Inspector and Etio and Ors. 3. That, in
the Counter-Affidavit filed by the Respondents No.1 and 2, as also
in the Budgetary Support Scheme, it is stated that the limited
benefit accorded is due to the reason that the Central Government
devolves 42 per cent of the Taxes on goods and services to the
State as per the recommendations of the 14th Finance Commission.
That, even prior to the GST regime, the Central Government was
sharing the revenue of Central Excise duty in the same proportion
with the State Governments and at the time of introduction of the
exemption Notification in 2003, the Centre was sharing 29.5 per
cent of the Central Taxes with the States. However, the Petitioner
was promised and granted 100 per cent exemption from Excise
duty and it was not restricted to 70.5 per cent of the Tax payable.
Hence, when the promises were made, the Parliament was well
aware of its obligation to share the revenue with the States. That,
the position under the GST Scheme is no different than the position
under the erstwhile Central Excise regime, whereby the Taxes were
(2006) 2 SCC 740
(2007) 5 SCC 447
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
shared by virtue of Article 270(1) of the Constitution. The
justification put forward by the Respondents on misuse of previous
Scheme, something that was specifically noted and was made the
basis of the Judgment in V.V.F. Limited (supra), is wholly without
merit and ex facie unsustainable. That, the Exemption granted to it
under the erstwhile Notifications were vested rights of the
Petitioner as recognized by the Hon’ble Supreme Court in V.V.F.
Limited (supra), which are saved by Section 174(2)(c) read with
Section 6 of the General Clauses Act, 1897 and do not fall under
the proviso to Sec 174(2)(c) of the said Act, which only seeks to
exclude a privilege and not a vested right. That, the Budgetary
Support Scheme being against the principles of Promissory
Estoppel is arbitrary and violative of Article 14 of the Constitution
and hence the Court may direct the Respondents to grant refund of
50 per cent IGST/100 per cent CGST, paid through cash on the
goods cleared by the Petitioner from its eligible units.
6.
Per contra the arguments submitted by Respondents
No.1 and 2 was that the Petitioner had filed an Interlocutory
Application being I.A. No.02 of 2019, stating that the Respondents
No.1 and 2 had filed an Appeal against the Judgment of this Court
dated 21.11.2017. When the matter was heard and reserved for
Judgment by the Hon’ble Supreme Court, the Petitioner prayed
that as the subject matter in the Special Leave Petitions dealt with
the same issue as in the present Writ Petition, this Writ Petition be
kept in abeyance till the pronouncement of the Judgment by the
Hon’ble Supreme Court.
Hence, the Judgment in V.V.F. Limited
(supra) is applicable to the facts and circumstances of the instant
case as evident from the observation at Paragraph “14.3” therein.
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
The Hon’ble Supreme Court had rejected the original Petition of the
Petitioner wherein they sought benefit on the ground of Promissory
Estoppel. Moreover, with the roll out of the GST regime, a new
Scheme offered a measure of goodwill unrelated otherwise to the
erstwhile Schemes. That, in fact, instead of 56 per cent exemption
that was granted earlier, the amount to be refunded is fixed at 58
per cent, giving the Petitioner the benefit of additional 2 per cent.
That although any tax exemption granted as an incentive against
investment through a Notification has been discounted as a
privilege vide Section 174(2)(c) of the CGST Act read with
Notification No.21/2017-C.E., dated 18.07.2017, the Petitioner has
been compensated for the benefits they were drawing earlier. That,
as per the recommendations of the 14th Finance Commission, the
Central Government devolves 42 per cent of the taxes on goods
and services to the States, hence, it has been considered to be
expedient in public interest and in the interest of revenue by the
Central Government. In view of the above grounds, the present
Petition deserves no consideration and is liable to be dismissed.
7.
Learned
Government
Advocate
for
the
State-
Respondent No.3, in his arguments, contended that the distribution
of Revenue Tax in accordance with the recommendation of the
Finance Commission in the proportion of 58 per cent to the Union
and 42 per cent to the States, is a recommendation involving all
States in the Indian Union and does not pertain to the State of
Sikkim alone. Of the 42 per cent which is distributed to the State,
the share of the State of Sikkim is less than 0.5 per cent and in
this view of the matter, it would be wholly erroneous to extrapolate
the number of 42 per cent on the recommendation, if any, to be
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
made to the Petitioner without taking into reference the share of
the State of Sikkim which is less than 0.5 per cent. That, the
“CGST” is a “Central Tax” and liability exacted by the Union. The
Union is solely responsible for the refund of the same and any
liability, if so found by this Court, would be irrational without any
fundamentals or any law.
8.
The rival submissions of Learned Counsel for the
parties were heard in extenso and given due consideration. The
decisions relied on by Learned Counsel for the parties have also
been perused as also the pleadings and all documents on record.
What thereby falls for consideration before this Court is whether
the ratio in V.V.F. Limited (supra) would be applicable to the facts
and circumstances of the instant case or does this matter require
independent examination by this Court.
9.(i)
It would be apposite firstly to recapitulate here that the
Petitioner had filed W.P.(C) No.41/2015, W.P.(C) No.08/2017,
W.P.(C) No.27/2017 and W.P.(C) No.40 of 2017 before this Court,
which came to be disposed of vide a common Judgment dated
21.11.2017.
(ii)
In W.P.(C) No.41/2015, Notification No.21/2008-C.E.
of 27.03.2008 and Notification No.36/2008-C.E. of 10.06.2008,
were impugned with the prayer that the Petitioner Units be
permitted to avail the benefits of Excise duty exemption provided
in
terms
Notification
of
Notification
No.20/2008-C.E.
No.56/2003-C.E.
of
25.06.2003.
of
and
Notification
27.03.2008
No.38/2008-C.E. of 10.06.2008, were also impugned with the
prayer seeking to avail the benefit of Excise duty exemption, as
provided in Notification No.20/2007-C.E. of 25.04.2007.
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
(iii)
Notification
Notification
vs.
Union of India and Others
No.21/2008-C.E.,
No.36/2008-C.E.,
dated
dated
10.06.2008;
27.03.2008;
Notification
No.20/2008-C.E., dated 27.03.2008 and Notification No.38/2008C.E., dated 10.06.2008 (also impugned in W.P.(C) No.41/2015)
were impugned in W.P.(C) No.27 of 2017.
(iv)
W.P.(C) No.40/2017 assailed Notification No.20/2008-
C.E., dated 27.03.2008 and Notification No.38/2008-C.E., dated
10.06.2008 (also impugned in W.P.(C) No.41/2015 and W.P.(C)
No.27/2017).
(v)
It is worthwhile mentioning that in the said Writ
Petitions, Learned Senior Counsel submitting on behalf of the
Petitioner inter alia canvassed the contention that based on the
Industrial Policy of 2003 and in terms of the promises made, which
also exempted from so much of the duty of Excise leviable thereon
as is equivalent to the amount of duty paid by manufacturer of the
goods other than the amount of duty paid by utilization of CENVAT
Credit under the CENVAT Credit Rules, 2002, for a period of ten
years from the date of commencement of commercial production,
the Petitioner, by investing large amounts of money, established
Units for the manufacture of P&P Medicaments falling under Serial
No.11 of the Schedule to the Notification No.56/2003-C.E., dated
25.06.2003.
In
the
meanwhile,
Office
Memorandum
dated
01.04.2007, was issued notifying the Industrial Policy, 2007, which
also granted 100 per cent Excise duty exemption as provided in the
Industrial Policy, 2003. That, however, the Industrial Policy, 2007,
specifically
provided
that
the
new
Industrial
Units
which
commenced production within ten years of the said Memorandum,
would be eligible for the incentive thereunder. In line with the
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
Industrial
Policy,
2007,
vs.
Union of India and Others
Notification
No.20/2007-C.E.,
dated
25.04.2007, was issued whereby the Petitioner’s goods were
exempted from so much of the duty of Excise leviable thereon as is
equivalent to the amount of duty paid by the manufacturer of
goods other than the amount of duty paid by utilization of CENVAT
Credit. In the year 2008, the earlier notified 100 per cent Excise
duty exemption was significantly curtailed by issuing two amending
impugned Notifications No.21/2008 and 20/2008 supra, by which
the benefit of exemption was limited to the certain prescribed
percentage of value addition i.e. 56 per cent applicable to
Pharmaceutical
Products,
as
mentioned
in
the
respective
Notifications. Further, amendment to Notifications No.56/2003 and
No.20/2007 was made vide impugned Notification No.36/2008-C.E.
(amending Notification No.56/2003) and impugned Notification
No.38/2008-C.E. (amending Notification No.20/2007) both dated
10.06.2008, whereby an option for fixation of special rates for
representing the actual value addition in respect of any goods
manufactured and cleared under the respective original Notification
was given. That, although the Petitioner was eligible to get the
benefit
of
inadvertently,
exemption
after
under
commencing
the
Industrial
commercial
Policy,
2007,
production from
20.04.2009, the Petitioner started claiming Excise duty benefit by
way of self-credit of Excise duty in cash for the period April, 2009
to May, 2012 at the reduced rate of 56 per cent instead of 100 per
cent of the amount paid in cash. No objection was taken to this
credit by the Petitioner. On coming to learn of the decision of this
Court in Unicorn Industries vs. Union of India4 and of the High Court
2013 (289) ELT 117 (Sikkim)
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
of Jammu and Kashmir in Reckitt Benckiser vs. Union of India5,
wherein
the
Notifications
curtailing
benefits
promised
under
Industrial Policy, 2003, were quashed, the Petitioner informed the
authorities on 22.10.2011 that it would avail 100 per cent selfcredit of the Excise duty paid, placing reliance on the aforesaid
Judgments. For the period June, 2012 to February, 2014, the
authorities denied self-credit on monthly basis on the ground that
the Petitioner was not eligible to claim the benefit at the rate of
100 per cent of the amount paid in cash but was eligible for refund
at the rate of 56 per cent on account of the amendment vide
impugned Notification No.21/2008-C.E., dated 27.03.2008, which
reduced the benefit from 100 per cent. That, the impugned
Notifications reduced the 100 per cent Excise duty guarantee to 56
per cent, hence, on the ground of Promissory Estoppel alone, the
Writ Petitions were liable to be allowed and the offending
Notifications and Orders of the Commissionerate quashed. Further,
once an exemption Notification has been issued in public interest,
the authority cannot, by simply saying it is in public interest,
withdraw or reduce its benefit and the onus would be on the
authority to establish a superior public interest for such curtailment
or withdrawal.
(vi)
The
Respondents
(in
the
Writ
Petitions
under
consideration then) while defending their action, claimed that a
different mechanism was devised in public good and that the
impugned Notification No.20/2008-C.E., dated 27.03.2008, does
not deviate from the 100 per cent policy. This was sought to be
explained by placing two separate calculations of Re-Credit/Refund
2011 (269) ELT 194
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
under Area Based Exemption Notification. That, the Petitioner had
started availing credit of the amount of duty paid other than by
way of utilization of CENVAT Credit under the CENVAT Credit Rules,
2004 at the rate of 56 per cent right from the beginning. That, the
Petitioner started paying Central Excise duty from the Personal
Ledger Account with effect from August, 2009, by which time, the
impugned
Notifications
No.21/2008,
dated
27.03.2008
and
36/2008, dated 10.06.2008, were already in existence and the
Respondent No.1 was empowered under Section 5A of the Central
Excise Act, 1944, to grant exemption from duty of Excise if the
Government was satisfied that it was necessary and in public
interest so to do by a Notification in the Official Gazette. That, the
Petitioner was duly entitled to claim the option for fixation of
special rate on the basis of the impugned Notification No.36/2008,
dated 10.06.2008.
(vii)
After hearing Learned Counsel for the parties and on
consideration of the averments thereto, the Court then took up the
following question for determination;
“47. The crucial question which must necessarily be
answered is whether the Petitioner has been able to
establish that the Respondents had vide the Industrial
Policy, 2007 and Notification No. 20/2007 made a promise,
which the Petitioner had acted upon putting itself in a
detrimental position which would compel the Respondent
No.1 to make good the promise. If the answer to the first
question is in the affirmative then the second question
which also needs to be answered is whether by issuing the
impugned Notification No.20/2008 the Respondents has
done away or curtailed the benefit granted under
Notification No.20/2007. To answer the first question it is
necessary to examine the pleadings in the present
proceedings.”
(viii)
On due consideration of all the facts and circumstances
placed before it, this Court observed as follows;
“64. As the Petitioner had failed to commence
commercial production within the period 23.12.2002 to
31.03.2017 as specified by Notification No. 56/2003 as
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
amended by Notification No.27/2004 it was not entitled to
claim exemption under the aforesaid notification as held
above. Consequently, we shall refrain from examining the
challenge to the impugned Notification Nos. 27/2004,
21/2008 and 36/2008.”
(emphasis supplied)
(ix)
While
examining
the
impugned
Notification
No.20/2008-C.E., dated 27.03.2008 and the point canvassed by
the Learned Additional Solicitor General that it does not actually
digress from the Industrial Policy, 2007, as put into operation by
Notification No.20/2007-C.E., dated 25.04.2007, the Court noted
inter alia as follows;
“67. Under the amended paragraph 2A of
Notification No.20/2007 as amended by impugned
Notification No. 20/2008 the duty payable on value addition
shall be equivalent to the amount calculated as a
percentage of the total duty payable on the excisable
goods. For the goods i.e. P & P medicaments falling under
chapter 30 of the first schedule, the rate prescribed in the
table to the amended paragraph 2A was 56%. Reading of
the amended paragraph 2A leaves no room for doubt that
the total 100% exemption once declared by the Industrial
Policy, 2007 and as put into operation by Notification No.
20/2007 was hugely reduced to only 56% that too only on
the value addition undertaken in the manufacture of the
said goods. Simply put value addition is the amount by
which the value of any good is increased at each stage of
its production, exclusive of initial cost. Whereas in the
original Notification No. 20/2007, the exemption on
payment of excise duty was referable to the excise duty
payable on the finished goods in the impugned Notification
No. 20/2008 the excise duty was restricted to the quantum
of value addition only. This surely was something not
promised vide the Industrial Policy, 2007 and Notification
No. 20/2007.”
(x)
This Court further expressed its agreement with the
views of the High Court of Gujarat in Sal Steel Limited vs. Union of
India6, Reckitt Benckiser (supra), Unicorn Industries (supra), Motilal
Padampat Sugar Mills Co. Ltd. vs. State of Uttar Pradesh and Others 7
and Pawan Alloys and Casting Pvt. Ltd., Meerut vs. U.P. State Electricity
Board and Others8 and at Paragraph “87” concluded, as follows;
(2010) 260 ELT 158 (Guj)
(1979) 2 SCC 409
(1997) 7 SCC 251
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
“87. We find that the Respondent No.1, right from
the year 2003, had declared a clear policy of 100% excise
duty exemption to those new industrial units who would set
up industry in Sikkim as well as to those industries who
went in for substantial expansion. This policy was put into
operation vide Notification No.56/2003. The Respondent
No.1 had vide impugned Notification No. 24/2004 limited
the period within which new industrial units were required
to commence commercial production. The Petitioner started
the process of investment in the year 2005 only and could
not start commercial production until 20.04.2009 by which
time, by the operation of a subsequent impugned
Notification No.27/2004, the Petitioner did not qualify to
take the benefit of the said Industrial Policy, 2003. The
Petitioner therefore, is not entitled to the benefit of
Notification No. 56/2003. The industrial policy however, did
not change. In 2007 the Respondent No.1 declared the
Industrial Policy, 2007 by which identical 100% excise duty
exemption was once again promised. This Industrial Policy,
2007 was put into operation vide Notification No.20/2007.
The Petitioner’s subsequent investments were obviously
intended to reap the benefit of the said Notification
No.20/2007. The Petitioner having commenced commercial
production on and from 20.04.2009 for the first unit and
from 14.04.2014 for the second unit were well within the
period notified therein. The policy of the Respondent No.1
was clear and cogent. It was intended to draw investors to
Sikkim which was industrially backward. Having acted on
the said promise made by the Respondent No.1, the
Petitioner made huge investments and altered its position
to its detriment. Having issued the said Notification
No.20/2007 in public interest it was incumbent upon the
Respondent No.1 to place before this Court all materials
available to establish a superior public interest which the
Respondent No.1 has failed to do. The facts and
circumstances of the present writ petitions, therefore,
squarely falls within the parameters of the doctrine of
promissory estoppel and that it would be unconscionable
on the part of the Respondent No.1 to shy away from it
without fulfilling its promise. The relief that must,
therefore be granted on the facts of the present case is
that for the period declared vide Notification No.20/2007
the Petitioner would be entitled to the excise duty
exemption as promised therein. Consequently impugned
Notification Nos.20/2008 and 38/2008 are liable to be
quashed to the extent they curtail and whittle down the
100% excise duty exemption benefit as promised vide
Notification No.20/2007 and is hereby quashed. All
impugned orders/ demand notices/show cause notices
which are against the aforestated declarations of law are
also quashed.”
(emphasis supplied)
10.(i)
As already stated, against the Judgment of this Court
dated 21.11.2017, the Union of India was in appeal before the
Hon’ble Supreme Court along with Judgments of various other High
Courts on similar issues. The Hon’ble Supreme Court, while
considering the Civil Appeals arising out of the various impugned
Judgments, observed in the case of Sikkim, that the High Court
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
had quashed and set aside Notification No.20 of 2008-C.E., dated
27.03.2008, Notification No.36 of 2008-C.E., dated 10.06.2008 and
Notification No.38 of 2008-C.E., dated 10.06.2008, on the ground
that the same were against the principle of Promissory Estoppel
and the Union of India.
(ii)
Before the Hon’ble Supreme Court, the Union of India
inter alia agitated that there was rampant misuse of Excise duty
exemption which was brought to the notice of the Government as
the Policy and intention of the Government to provide Excise duty
exemption was in respect of genuine manufacturing activities
carried out in those areas. The entire genesis of the Policy
manifesting the intention of the Government to grant Excise duty
exemption, was to provide such exemption only to actual value
addition made in these areas. In this background and with a view
to give effect to such a Policy, the Government in exercise of
powers conferred under Section 5A of the Central Excise Act, 1944
modified the refund mechanism so as to provide that Excise duty
refund would be allowed only to the extent of duty payable on
actual value addition made by the manufacturer undertaking
manufacturing activities in these areas. That, as a result of the
Notifications impugned before the High Court, the manufacturers
are required to pay duty on full value of the goods manufactured
and cleared by them in the same manner as per existing Scheme
but refund would be granted only to the extent of duty paid on the
value addition made by them in these specified areas based on all
India average of percentage of duty paid in cash and CENVAT
Credit. That, the Central Government has the power to provide for
exemption from duty on goods either wholly or partly with or
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
without condition as may be called for in public interest which is
the guiding factor for exercise of power. That, the amendment
Notification is non-discriminatory and treats all industries at par,
and only rationalizes the quantum of exemption by proposing rate
of refund on the total duty payable and the Central Government
has only streamlined the provisions of the Notification relating to
refund of duty paid through, other than CENVAT utilization. That,
moreover, the doctrine of Promissory Estoppel cannot be invoked
against exercise of powers under the statute and the bar of
Promissory Estoppel is not applicable in fiscal matters, besides
which, the doctrine of Promissory Estoppel will not be applicable if
the change in stand of the Government is made on account of
public policy and in public interest.
(iii)
The Hon’ble Supreme Court inter alia held as follows;
“10. …………Therefore, the questions which are posed
for consideration of this Court are whether in the facts and
circumstances of the case the subsequent notification
which has been quashed and set aside by the High Court
being notification No. 16 of 2008 dated 27.03.2008 can be
said to be clarificatory in nature and can it be said that it
takes away the vested right conferred pursuant to the
earlier notification of 2001 and whether the same can be
made applicable retrospectively and whether the same has
been issued in the public interest and whether the same is
hit by the Doctrine of Promissory Estoppel?
11.
While considering the aforesaid questions
and before considering the nature of the subsequent
notification of 2008, few decisions of this Court on
retrospectivity/clarificatory/applicability
of
promissory
estoppel in the fiscal statute are required to be referred to,
which are as under:
11.1
In the case of Kasinka Trading (supra), in
paragraphs 12, 20 and 23, it is observed and held as
follows:
“12. It has been settled by this Court
that the doctrine of promissory estoppel is
applicable against the Government also
particularly where it is necessary to prevent
fraud or manifest injustice. The doctrine,
however, cannot be pressed into aid to compel
the Government or the public authority “to
carry out a representation or promise which is
contrary to law or which was outside the
authority or power of the officer of the
Government or of the public authority to
make”. There is preponderance of judicial
opinion that to invoke the doctrine of
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
promissory estoppel clear, sound and positive
foundation must be laid in the petition itself by
the party invoking the doctrine and that bald
expressions, without any supporting material,
to the effect that the doctrine is attracted
because the party invoking the doctrine has
altered its position relying on the assurance of
the Government would not be sufficient to
press into aid the doctrine. In our opinion, the
doctrine of promissory estoppel cannot be
invoked in the abstract and the courts are
bound to consider all aspects including the
results sought to be achieved and the public
good at large, because while considering the
applicability of the doctrine, the courts have to
do equity and the fundamental principles of
equity must for ever be present to the mind of
the court, while considering the applicability of
the doctrine. The doctrine must yield when the
equity so demands if it can be shown having
regard to the facts and circumstances of the
case that it would be inequitable to hold the
Government or the public authority to its
promise, assurance or representation.
20. The facts of the appeals before us
are not analogous to the facts in Indo-Afghan
Agencies [(1968) 2 SCR 366 : AIR 1968 SC
718] or M.P. Sugar Mills [(1979) 2 SCC 409 :
1979 SCC (Tax) 144 : (1979) 2 SCR 641] . In
the first case the petitioner therein had acted
upon the unequivocal promises held out to it
and exported goods on the specific assurance
given to it and it was in that fact situation that
it was held that Textile Commissioner who had
enunciated the scheme was bound by the
assurance thereof and obliged to carry out the
promise made thereunder. As already noticed,
in the present batch of cases neither the
notification is of an executive character nor
does it represent a scheme designed to achieve
a particular purpose. It was a notification
issued in public interest and again withdrawn in
public interest. So far as the second case (M.P.
Sugar Mills case [(1979) 2 SCC 409 : 1979 SCC
(Tax) 144 : (1979) 2 SCR 641] ) is concerned
the facts were totally different. In the
correspondence exchanged between the State
and the petitioners therein it was held out to
the petitioners that the industry would be
exempted from sales tax for a particular
number of initial years but when the State
sought to levy the sales tax it was held by this
Court that it was precluded from doing so
because of the categorical representation made
by it to the petitioners through letters in
writing, who had relied upon the same and set
up the industry.
23. The appellants appear to be under
the impression that even if, in the altered
market conditions the continuance of the
exemption may not have been justified, yet,
Government was bound to continue it to give
extra profit to them. That certainly was not the
object with which the notification had been
issued. The withdrawal of exemption “in public
interest” is a matter of policy and the courts
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
would not bind the Government to its policy
decisions for all times to come, irrespective of
the satisfaction of the Government that a
change in the policy was necessary in the
“public interest”. The courts, do not interfere
with the fiscal policy where the Government
acts in “public interest” and neither any fraud
or lack of bona fides is alleged much less
established. The Government has to be left free
to determine the priorities in the matter of
utilisation of finances and to act in the public
interest while issuing or modifying or
withdrawing an exemption notification under
Section 25(1) of the Act.”
Thus, it can be seen that this Court has specifically and
clearly held that the doctrine of promissory estoppel cannot
be invoked in the abstract and the courts are bound to
consider all aspects including the objective to be achieved
and the public good at large. It has been held that while
considering the applicability of the doctrine, the courts
have to do equity and the fundamental principles of equity
must forever be present to the mind of the court, while
considering the applicability of the doctrine. It is further
held that the doctrine must yield when the equity so
demands if it can be shown having regard to the facts and
circumstances of the case that it would be inequitable to
hold the Government or the public authority to its promise,
assurance or representation. It is further held that an
exemption notification does not make items which are
subject to levy of customs duty etc. as items not leviable to
such duty. It only suspends the levy and collection of
customs duty, etc., wholly or partially and subject to such
conditions as may be laid down in the notification by the
Government in “public interest”. Such an exemption by its
very nature is susceptible of being revoked or modified or
subjected to other conditions. The supersession or
revocation of an exemption notification in the “public
interest” is an exercise of the statutory power of the State
under the law itself. It has been further held that under the
General Clauses Act an authority which has the power to
issue a notification has the undoubted power to rescind or
modify the notification in a like manner. It has been
observed that the withdrawal of exemption “in public
interest” is a matter of policy and the courts would not bind
the Government to its policy decisions for all times to
come, irrespective of the satisfaction of the Government
that a change in the policy was necessary in the “public
interest”. It has been held that where the Government acts
in “public interest” and neither any fraud or lack of
bonafides is alleged, much less established, it would not be
appropriate for the court to interfere with the same.
11.2
In the case of Shrijee Sales Corporation
(supra), it is observed and held that the principle of
promissory estoppel may be applicable against the
Government. But the determination of applicability of
promissory estoppel against public authority/Government
hinges upon balance of equity or “public interest”. In case
there is a supervening public interest, the Government
would be allowed to change its stand; it would then be able
to withdraw from representation made by it which induced
persons to take certain steps which may have gone
adverse to the interest of such persons on account of such
withdrawal. Once public interest is accepted as the superior
equity which can override individual equity, the aforesaid
principle should be applicable even in cases where a period
has been indicated for operation of the promise.
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
………………………………………………………………………………………………..
12.
Now, so far as the decisions relied upon by
the learned counsel appearing on behalf of the respective
original writ petitioners-respondents herein are concerned,
once it is held that the subsequent notifications/industrial
policies impugned before the respective High Court are
clarificatory in nature and it does not take away any vested
rights conferred under the earlier notifications/industrial
policies, none of the decisions relied upon shall be
applicable to the facts of the case on hand.”
(emphasis supplied)
(iv)
Reference was also made to the ratio in Sales Tax
Officer and Another vs. Shree Durga Oil Mills and Another 9, State of
Rajasthan and Another vs. Mahaveer Oil Industries and Others 10 and
Shree Sidhbali Steels Limited and Others vs. State of Uttar Pradesh and
Others11.
The Hon’ble Supreme Court also explained that any
legislation or instrument having force of law, if clarificatory,
declaratory
or
explanatory
in
nature
or
purport,
will
have
retrospective operation especially in the absence of any indication
to the contrary as to retrospectivity either in parent Act or Rules or
Notifications involved and held inter alia as follows;
“14.1 The main objective of the earlier respective
notifications/industrial policies was to encourage the
entrepreneurs to put new industries in the area so as to
generate employment and for that an incentive was offered
to get back by way of refund the excise duty paid either in
cash or PLA, namely, the amount of duty paid by the
manufacturer of goods other than the amount of duty paid
by utilization paid by CENVAT credit. The same was subject
to conditions that it will be applied to the new industrial
units, i.e. the units which are set up on and after the
publication of the said notification in the Official Gazette,
i.e. not later than 31.07.2003. The notification was
modified from time to time. However, during the operation
of the earlier notifications, it was noticed that the provision
of granting refund of cash paid portion of duty and
eligibility of credit the entire amount of duty to the buyers
of such excisable goods had prompted certain unscrupulous
manufacturers to indulge in different types of tax evasion
tactics. It was revealed on analysis of cases booked by the
Excise Department and even the representations received
from the Industry Association about misuse of exemptions
granted by the Government, which was meant to be
available only for genuine manufacturers. It was noticed as
under:
i)
Reporting of bogus production by mere
issuance of sale invoices without actual
production of goods and supply/clearance of
(1998) 1 SCC 572
(1999) 4 SCC 357
(2011) 3 SCC 193
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
excisable goods. This would result in
availment of CENVAT credit by buyers of
such excisable goods in other parts of the
country without actual production being
carried out and in absence of actual receipt
of goods.
ii)
Reporting of bogus production by such units
in these areas where actual production takes
place elsewhere in the country.
iii)
Over valuation of goods resulting in
availment of excess credit by buyers.
iv)
Goods are supplied by manufacturers,
importers to these units without issuance of
sales invoice and these are backed by bogus
sale invoices issued by traders who do not
undertake actual supply of goods. The actual
supplier of these goods issue bogus duty paid
invoices to other manufacturers who take
credit based on such invoices without receipt
of goods.
Therefore, the Government came out with the impugned
notifications/industrial policies that the refund of excise
duty shall be provided on actual and calculated on the basis
of actual value addition. On a fair reading of the earlier
notifications/ industrial policies, it is clear that the object of
granting the refund was to refund the excise duty paid on
genuine manufacturing activities. The intention would not
have been that irrespective of actual manufacturing/
manufacturing activities and even if the goods are not
actually manufactured, but are manufactured on paper,
there shall be refund of excise duty which are
manufactured on paper. Therefore, it can be said that the
object of the subsequent notifications/industrial policies
was the prevention of tax evasion. It can be said that by
the subsequent notifications/industrial policies, they only
rationalizes the quantum of exemption and proposing rate
of refund on the total duty payable on the genuine
manufactured goods. At the time when the earlier
notifications were issued, the Government did not visualize
that such a modus operandi would be followed by the
unscrupulous manufacturers who indulge in different types
of tax evasion tactics. It is only by experience and on
analysis of cases detected the Excise Department the
Government came to know about such tax evasion tactics
being followed by the unscrupulous manufacturers which
prompted the Government to come out with the
subsequent notifications which, as observed hereinabove,
was to clarify the refund mechanism so as to provide that
excise duty refund would be allowed only to the extent of
duty payable on actual value addition made by the
manufacturer undertaking manufacturing activities in the
concerned areas. The entire genesis of the policy
manifesting the intention of the Government to grant
excise duty exemption/refund of excise duty paid was to
provide such exemption only to actual value addition made
in the respective areas. As it was found that there was
misuse of excise duty exemption it was considered
expedient in the public interest and with a laudable object
of having genuine industrialization in backward areas or
the concerned areas, the subsequent notifications/
industrial policies have been issued by the Government.
Therefore, the subsequent notifications/industrial policies
impugned before the respective High Courts were in the
public interest and even issued after thorough analysis of
the cases of tax evasion and even after receipt of the
reports. The earlier notifications were issued under Section
5A of the Central Excise Act and even the subsequent
notifications which were issued in public interest and in
the interest of Revenue were also issued under Section 5A
of the Central Excise Act, which can not be said to be bad
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
in law, arbitrary and/or hit by the doctrine of promissory
estoppel.
14.2 The purpose of the original scheme was not to
give benefit of refund of the excise duty paid on the goods
manufactured only on paper or in fact not manufactured at
all. As the purpose of the original notifications/incentive
schemes was being frustrated by such unscrupulous
manufacturers who had indulged in different types of tax
evasion tactics, the subsequent notifications/industrial
policies have been issued allowing refund of excise duty
only to the extent of duty payable on the actual value
addition made by the manufacturers undertaking
manufacturing activities in these areas which is absolutely
in consonance with the incentive scheme and the intention
of the Government to provide the excise duty exemption
only in respect of genuine manufacturing activities carried
out in these areas.
14.3 As observed hereinabove, the subsequent
notifications/industrial policies do not take away any
vested
right
conferred
under
the
earlier
notifications/industrial policies. Under the subsequent
notifications/industrial policies, the persons who establish
the new undertakings shall be continue to get the refund of
the excise duty. However, it is clarified by the subsequent
notifications that the refund of the excise duty shall be on
the actual excise duty paid on actual value addition made
by
the
manufacturers
undertaking
manufacturing
activities. Therefore, it cannot be said that subsequent
notifications/industrial policies are hit by the doctrine of
promissory estoppel. The respective High Courts have
committed grave error in holding that the subsequent
notifications/industrial policies impugned before the
respective High Courts were hit by the doctrine of
promissory estoppel. As observed and held hereinabove,
the subsequent notifications/industrial policies which were
impugned before the respective High Court can be said to
be clarificatory in nature and the same have been issued in
the larger public interest and in the interest of the
Revenue, the same can be made applicable retrospectively,
otherwise the object and purpose and the intention of the
Government to provide excise duty exemption only in
respect of genuine manufacturing activities carried out in
the concerned areas shall be frustrated. As the subsequent
notifications/industrial policies are “to explain” the earlier
notifications/industrial policies, it would be without object
unless
construed
retrospectively.
The
subsequent
notifications impugned before the respective High Courts
as such provide the manner and method of calculating the
amount of refund of excise duty paid on actual
manufacturing of goods. The notifications impugned before
the respective High Courts can be said to be providing
mode on determination of the refund of excise duty to
achieve the object and purpose of providing incentive/
exemption. As observed hereinabove, they do not take
away any vested right conferred under the earlier
notifications. The subsequent notifications therefore are
clarificatory in nature, since it declares the refund of excise
duty paid genuinely and paid on actual manufacturing of
goods and not on the duty paid on the goods manufactured
only on paper and without undertaking any manufacturing
activities of such goods.
15. In view of the above and for the reasons stated
above and once it is held that the subsequent
notifications/industrial policies which were impugned before
the respective High Courts are clarificatory in nature and
are issued in public interest and in the interest of the
Revenue and they seek to achieve the original object and
purpose of giving incentive/exemption while inviting the
persons to make investment on establishing the new
undertakings and they do not take away any vested rights
conferred under the earlier notifications/industrial policies
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
and therefore cannot be said to be hit by the doctrine of
promissory estoppel, the same is to be applied
retrospectively and they cannot be said to be irrational
and/or arbitrary.”
(emphasis supplied)
Learned Counsel for the Petitioner has admitted that the Hon’ble
Supreme Court, while examining the reduction in Excise duty
exemption benefits, held that the subsequent Notifications were
merely clarificatory in nature and did not take away any vested
right and had, in fact, been issued in the larger public interest to
prevent misuse and to achieve the original object and purpose of
the incentive/exemption.
11.
On a meticulous scrutiny of the pleadings before us and
from a careful consideration of the facts canvassed by Learned
Counsel for the parties, it goes without saying that the issues
raised in the previous Writ Petitions determined by this Court vide
Judgment dated 21.11.2017, are identical to the issues raised in
the instant Writ Petition viz. W.P.(C) No.47 of 2018, the only
distinguishing factor being that the Notification challenged herein is
“Notification
F.No.10(1)/2017-DBA-II/NER,”
dated
05.10.2017,
while the Notifications challenged in the earlier Writ Petitions have
already been enumerated hereinabove.
12.(i)
The Petitioner, in the instant Writ Petition, is aggrieved
by the alleged curtailment of 100 per cent Excise duty exemption
granted vide the earlier Policies of the Government, which
underwent a sea change under the new Tax regime in 2017. That,
the 100 per cent Excise duty exemption by way of refund availed
by the Petitioner prior to the Tax Reform of 2017, was curtailed by
the Respondents under the GST regime through the Budgetary
Support Schemes reducing the benefits earlier granted inasmuch
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
as the Budgetary Support for specified goods manufactured by the
eligible Unit is 58 per cent of CGST and 29 per cent of IGST paid
through debit in cash ledger account maintained by the Unit after
full utilization of the input Tax Credit of the Central Tax and
Integrated Tax. The Petitioner in W.P.(C) No.41/2015, W.P.(C)
No.08/2017, W.P.(C) No.27/2017 and W.P.(C) No.40 of 2017 had
in sum and substance, the same grievances. Promissory Estoppel
has been agitated previously, as also in this Writ Petition. In
W.P.(C) No.41/2015, the challenge to the impugned Notifications
therein was for the reason that the benefit of exemption was
sought to be reduced to the prescribed percentage of value
addition amount i.e. 56 per cent applicable to pharmaceutical
products mentioned in the respective Notifications and applicable
Chapter. In the instant Petition, it is contended that the amount of
Budgetary
Support
under
the
Scheme
for
specified
goods
manufactured by the eligible Unit is specified as the sum total of 58
per cent of the Central Tax paid through debit in cash ledger
account maintained by the Unit after full utilization of the input Tax
Credit of the Central Tax and Integrated Tax and 29 per cent of the
Integrated
Tax
paid
through
debit
in
cash
ledger
account
maintained by the Unit after full utilization of the input Tax Credit
of the Central Tax and Integrated Tax. That, hence the Excise duty
Exemptions availed by the Petitioner by way of refund in the pre
GST regime, for both the Units were curtailed by the Respondent
No.1 through the Budgetary Support Policy thereby reducing the
benefit granted to the Petitioner, as the Petitioner is not allowed to
take refund of full amount of CGST paid from electronic cash ledger
and the refund of 50 per cent of the IGST paid from electronic cash
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
ledger. In fact, it was the submission of Learned Counsel for the
Petitioner in I.A. No.02 of 2019, before this Court, that the subject
matter in the SLP(s) supra dealt with the same issue as in the
instant Writ Petition. It is relevant to notice that the Order of this
Court, dated 17.09.2019, in the said I.A., reads inter alia as
follows;
“Heard on I.A. No.02 of 2019 which is an application
filed by the Petitioner, i.e., Sun Pharma Laboratories
Limited, bringing on record subsequent developments
relating to the subject-matter of WP(C) No.47 of 2018,
which was finally heard on 03-09-2019 and Judgment
reserved.
It is submitted by Learned Counsel for the Petitioner
that the Respondents No.1 and 2 filed SLP(C) Nos.10257 of
2018, 10253 of 2018, 12148 of 2018 and 12496 of 2018,
before the Hon’ble Supreme Court, against the Judgment of
this Court dated 21-11-2017 in WP(C) Nos. 41 of 2015, 8
of 2017, 27 of 2017 and 40 of 2017. That, the said Appeals
have been heard by the Hon’ble Supreme Court and
Judgment is reserved in those matters. As the subjectmatter in the SLP(s) supra deal with the same issue as in
WP(C) No.47 of 2018, it is prayed that the Judgment in this
Writ Petition be kept in abeyance till the pronouncement of
the Judgment by the Hon’ble Supreme Court in the
aforestated SLP(s).
The other parties have no objection.
Considered and ordered accordingly.
Let the Petitioner inform this Court after the
pronouncement of the Judgment by the Hon’ble Supreme
Court by filing a Petition to that effect.”
(emphasis supplied)
13.
The question framed in Paragraph “47” by this Court in
the impugned Judgment, dated 21.11.2017, as already extracted
supra, clearly deals with Promissory Estoppel and has been duly
examined by this Court. The Judgment of the Hon’ble Supreme
Court extracted hereinabove, therefore, elucidates and clarifies the
nature of the Notifications, while dealing with the amendments to
the impugned Notifications, as also the principle of Promissory
Estoppel and has clarified all points in controversy raised in the
Appeals, which without a shade of doubt, are similar to the issue
raised herein viz. curtailment of benefits granted vide exemptions.
Thus, these issues stand truncated and there is no question of this
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
vs.
Union of India and Others
Court delving any further into the question of the Promissory
Estoppel.
14.
That having been said, we may notably refer to the
ratio of the Hon’ble Supreme Court in Director of Settlements, A.P.
and Others vs. M.R. Apparao and Another12 which, while dealing with
the principle of binding precedent, held inter alia as follows;
“7. ……………….Article 141 of the Constitution
unequivocally indicates that the law declared by the
Supreme Court shall be binding on all courts within the
territory of India. The aforesaid Article empowers the
Supreme Court to declare the law. It is, therefore, an
essential function of the Court to interpret a legislation. The
statements of the Court on matters other than law like
facts may have no binding force as the facts of two cases
may not be similar. But what is binding is the ratio of the
decision and not any finding of facts. It is the principle
found out upon a reading of a judgment as a whole, in the
light of the questions before the Court that forms the ratio
and not any particular word or sentence. To determine
whether a decision has “declared law” it cannot be said to
be a law when a point is disposed of on concession and
what is binding is the principle underlying a decision. A
judgment of the Court has to be read in the context of
questions which arose for consideration in the case in
which the judgment was delivered. An “obiter dictum” as
distinguished from a ratio decidendi is an observation by
the Court on a legal question suggested in a case before it
but not arising in such manner as to require a decision.
Such an obiter may not have a binding precedent as the
observation was unnecessary for the decision pronounced,
but even though an obiter may not have a binding effect as
a precedent, but it cannot be denied that it is of
considerable weight. The law which will be binding under
Article 141 would, therefore, extend to all observations of
points raised and decided by the Court in a given case. So
far as constitutional matters are concerned, it is a practice
of the Court not to make any pronouncement on points not
directly raised for its decision. The decision in a judgment
of the Supreme Court cannot be assailed on the ground
that certain aspects were not considered or the relevant
provisions were not brought to the notice of the
Court…………………..”
(emphasis supplied)
15.
In conclusion, the grievances of the Petitioner raised in
the matter at hand is soundly quelled by the Hon’ble Supreme
Court in all aspects by the ratio in V.V.F. Limited (supra) and this
Court does not intend to venture further.
(2002) 4 SCC 638
WP(C) No.47 of 2018
Sun Pharma Laboratories Ltd.
16.
vs.
Union of India and Others
Hence, in view of all of the foregoing discussions, we
find no merit in the Writ Petition, which deserves to be and is
accordingly dismissed.
17.
No order as to costs.
( Bhaskar Raj Pradhan )
ml
( Meenakshi Madan Rai )
Judge
Judge
05.02.2021
05.02.2021
Approved for reporting : Yes
This page is for informational and research purposes only and does not constitute legal advice.
Consult a qualified advocate for advice specific to your situation.
Is your name in this judgment and should it be masked, or is something on this page wrong?
Request a review